DIER MARDI (EVP and CFO) sold 13.7% of their position (1.98K shares) of MADRIGAL PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $854.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+5.21K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−646.00
Price / share
$431.94
Trade value
$279.03K
% of position
Common Stock
Shares
−40.00
Price / share
$425.08
Trade value
$17K
% of position
Common Stock
Shares
−420.00
Price / share
$426.86
Trade value
$179.28K
% of position
Common Stock
Shares
−80.00
Price / share
$427.85
Trade value
$34.23K
% of position
Common Stock
Shares
−160.00
Price / share
$429.00
Trade value
$68.64K
% of position
Common Stock
Shares
−40.00
Price / share
$429.58
Trade value
$17.18K
% of position
Common Stock
Shares
−120.00
Price / share
$430.90
Trade value
$51.71K
% of position
Common Stock
Shares
−116.00
Price / share
$432.56
Trade value
$50.18K
% of position
Common Stock
Shares
−160.00
Price / share
$434.20
Trade value
$69.47K
% of position
Common Stock
Shares
−80.00
Price / share
$435.31
Trade value
$34.83K
% of position
Common Stock
Shares
−80.00
Price / share
$436.69
Trade value
$34.94K
% of position
Common Stock
Shares
−40.00
Price / share
$437.65
Trade value
$17.51K
% of position
Net shares
+3.23K
Net value
-$853.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/4/2026 | A · Award | +5.21K | — | — | 56.3% | 9.26K | 14.47K |
| Common Stock Direct | 3/6/2026 | S · Sale | −646.00 | $431.94 | $279.03K | 4.5% | 14.47K | 13.83K |
| Common Stock Direct | 3/6/2026 | S · Sale | −40.00 | $425.08 | $17K | 0.3% | 13.83K | 13.79K |
| Common Stock Direct | 3/6/2026 | S · Sale | −420.00 | $426.86 | $179.28K | 3.0% | 13.79K | 13.37K |
| Common Stock Direct | 3/6/2026 | S · Sale | −80.00 | $427.85 | $34.23K | 0.6% | 13.37K | 13.29K |
| Common Stock Direct | 3/6/2026 | S · Sale | −160.00 | $429.00 | $68.64K | 1.2% | 13.29K | 13.13K |
| Common Stock Direct | 3/6/2026 | S · Sale | −40.00 | $429.58 | $17.18K | 0.3% | 13.13K | 13.09K |
| Common Stock Direct | 3/6/2026 | S · Sale | −120.00 | $430.90 | $51.71K | 0.9% | 13.09K | 12.97K |
| Common Stock Direct | 3/6/2026 | S · Sale | −116.00 | $432.56 | $50.18K | 0.9% | 12.97K | 12.85K |
| Common Stock Direct | 3/6/2026 | S · Sale | −160.00 | $434.20 | $69.47K | 1.2% | 12.85K | 12.69K |
| Common Stock Direct | 3/6/2026 | S · Sale | −80.00 | $435.31 | $34.83K | 0.6% | 12.69K | 12.61K |
| Common Stock Direct | 3/6/2026 | S · Sale | −80.00 | $436.69 | $34.94K | 0.6% | 12.61K | 12.53K |
| Common Stock Direct | 3/6/2026 | S · Sale | −40.00 | $437.65 | $17.51K | 0.3% | 12.53K | 12.49K |
| Total | +3.23K | -$853.99K | ||||||
Stock Option (Right to Buy)
Common Stock
6.52K shares
Shares
+6.52K
Strike price
434.80
Held after
6.52K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock6.52K shares | 3/4/2026 | A · Award | +6.52K | 434.80 | — | 6.52K |